Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 2514Session 2025

Health and Human Services

S 2514 er

Underlined text would be added to current law. Struck-through text would be removed.

ENROLLED 2025 Legislature SB 2514, 1st Engrossed 20252514er 1 2 An act relating to health and human services; amending 3 s. 381.4019, F.S.; authorizing certain dental and 4 dental hygiene students to apply for the Dental 5 Student Loan Repayment Program before obtaining active 6 employment; amending s. 381.915, F.S.; revising the 7 definitions of the terms “cancer center” and “Florida 8 based”; defining the term “Cancer Connect 9 Collaborative” or “collaborative”; making clarifying 10 changes; deleting an obsolete date; revising the 11 composition of the collaborative; deleting obsolete 12 provisions; requiring the collaborative to review all 13 submitted Cancer Innovation Fund grant applications 14 using certain parameters; requiring the collaborative 15 to give priority to certain applications; requiring 16 that licensed or certified health care providers, 17 facilities, or entities meet certain criteria to be 18 eligible for specified grant funding; specifying such 19 criteria; requiring the Department of Health to 20 appoint peer review panels for a specified purpose; 21 requiring that priority scores be forwarded to the 22 collaborative and be considered in determining which 23 proposals the collaborative recommends for certain 24 grant funding; requiring the collaborative and peer 25 review panels to establish and follow certain 26 guidelines and adhere to a certain policy; prohibiting 27 a member of the collaborative or a panel from 28 participating in certain discussions or decisions 29 under certain circumstances; requiring, beginning on a 30 specified date and annually thereafter, the 31 collaborative to prepare and submit a specified report 32 to the Governor and the Legislature; requiring that 33 the report include certain information; revising the 34 requirements for a specified report by the department; 35 requiring, beginning on a specified date, that certain 36 allocation agreements include certain information; 37 providing legislative findings; creating the Cancer 38 Connect Collaborative Research Incubator within the 39 department, and overseen by the collaborative, to 40 provide funding for a specified purpose over a 41 specified timeframe; specifying the incubator’s 42 targeted area of cancer research for the first 43 specified timeframe; providing that grants issued 44 through the incubator are contingent upon the 45 appropriation of funds and must be awarded through a 46 specified process; requiring that priority be given to 47 certain applicants; authorizing the prioritization of 48 certain grant proposals; providing that applications 49 for incubator funding may be submitted by specified 50 hospitals; requiring that all qualified applicants 51 have equal access and opportunity to compete for 52 research funding; requiring that incubator grants be 53 recommended by the collaborative and awarded by the 54 department in a certain manner; requiring the 55 department to appoint peer review panels for a 56 specified purpose; requiring that priority scores be 57 forwarded to the collaborative and be considered in 58 determining which proposals the collaborative 59 recommends for funding; requiring the collaborative 60 and peer review panels to establish and follow certain 61 guidelines and adhere to a certain policy; prohibiting 62 a member of the collaborative or a panel from 63 participating in certain discussions or decisions; 64 requiring recipients of incubator grant funds to enter 65 into an allocation agreement with the department; 66 specifying requirements for such allocation 67 agreements; requiring, beginning on a specified date 68 and annually until a specified date, the collaborative 69 to prepare and submit a specified report to the 70 Governor and the Legislature; requiring the 71 collaborative to make a certain recommendation under 72 certain circumstances; requiring that a specified 73 report include certain information; amending s. 74 381.922, F.S.; establishing the Bascom Palmer Eye 75 Institute VisionGen Initiative within the William G. 76 “Bill” Bankhead, Jr., and David Coley Cancer Research 77 Program; providing the purpose of the initiative; 78 providing that funding for the initiative is subject 79 to annual appropriation; amending s. 381.986, F.S.; 80 requiring the department to revoke the medical 81 marijuana use registry registration of qualified 82 patients and caregivers who enter certain pleas or are 83 found guilty of certain offenses; authorizing a person 84 seeking reinstatement of qualified patient or 85 caregiver registration to submit a new application 86 with a certain attestation; providing criminal 87 penalties for knowingly making a false attestation; 88 reviving, reenacting, and amending s. 400.0225, F.S., 89 relating to consumer satisfaction surveys; requiring 90 the Agency for Health Care Administration to develop 91 user-friendly consumer satisfaction surveys for 92 nursing home facilities; specifying requirements for 93 the surveys; authorizing family members, guardians, 94 and other resident designees to assist the resident in 95 completing the survey; prohibiting employees and 96 volunteers of the facility or of a corporation or 97 business entity with an ownership interest in the 98 facility from attempting to influence a resident’s 99 responses to the survey; requiring the agency to 100 specify certain protocols for administration of the 101 survey; requiring the agency to publish on its website 102 aggregated survey data in a manner that allows for 103 comparison between nursing home facilities; amending 104 s. 400.141, F.S.; requiring medical directors of 105 nursing home facilities to obtain, or to be in the 106 process of obtaining, certain qualifications by a 107 specified date; requiring the agency to include such 108 medical director’s name on each nursing home 109 facility’s online provider profile; requiring nursing 110 home facilities to conduct biennial patient safety 111 culture surveys; specifying requirements for 112 administration of such surveys; requiring nursing home 113 facilities to submit the results of such surveys 114 biennially to the agency in a format specified by 115 agency rule; authorizing nursing home facilities to 116 develop an internal action plan between surveys to 117 identify measures for improvement of the survey and 118 submit such plan to the agency; amending s. 400.191, 119 F.S.; requiring the agency to include the results from 120 specified consumer satisfaction surveys as part of the 121 Nursing Home Guide on its website; amending s. 122 408.051, F.S.; requiring nursing home facilities that 123 maintain certain electronic health records to make 124 available certain data to the agency’s Florida Health 125 Information Exchange program for a specified purpose; 126 authorizing the agency to adopt rules; amending s. 127 408.061, F.S.; exempting nursing homes operated by 128 state agencies from certain financial reporting 129 requirements; requiring the agency to impose 130 administrative fines against nursing homes and home 131 offices of nursing homes for failing to comply with 132 certain reporting requirements; defining the term 133 “violation”; providing construction; requiring the 134 agency to adopt rules; providing requirements for such 135 rules; amending s. 408.08, F.S.; prohibiting nursing 136 homes subject to certain administrative fines from 137 being fined under a specified provision for the same 138 violation; amending s. 409.904, F.S.; providing a 139 presumption of eligibility for continued coverage of 140 certain services for certain persons during a 141 redetermination process; requiring certain persons to 142 notify the agency and the Department of Children and 143 Families of certain material changes; authorizing the 144 department to conduct a redetermination of 145 eligibility; requiring the department to provide 146 certain persons notification and the results of such 147 redeterminations; requiring the agency to seek federal 148 authorization to exempt certain persons from annual 149 redetermination of eligibility by a certain date; 150 requiring the agency and department to develop a 151 certain process; amending s. 409.906, F.S.; 152 authorizing the agency to pay for certain blood-based 153 biomarker tests; amending s. 409.908, F.S.; requiring 154 the agency to revise its methodology for calculating 155 Quality Incentive Program payments; providing 156 requirements for such revision; requiring the agency 157 to submit an annual report to the Governor and the 158 Legislature on payments made under the Quality 159 Incentive Program; specifying requirements for the 160 report; amending s. 409.909, F.S.; revising the number 161 of resident positions for which the agency may 162 allocate certain funding to hospitals and qualifying 163 institutions; deleting provisions creating the 164 Graduate Medical Education Committee within the 165 agency; amending s. 409.91256, F.S.; revising the 166 purpose of the Training, Education, and Clinicals in 167 Health Funding Program; revising the definition of the 168 term “qualified facility”; specifying an allowed 169 reimbursement rate to qualified facilities under the 170 program for nursing students; amending s. 409.967, 171 F.S.; requiring the agency to review certain audit 172 reports for compliance; requiring a certified public 173 accountant to correct certain audit report 174 deficiencies and resubmit the report before the report 175 is considered final; amending s. 409.9745, F.S.; 176 requiring a managed care plan to provide coverage for 177 certain blood-based biomarker tests; amending s. 178 409.977, F.S.; authorizing the agency to exceed a 179 certain amount of financial assistance for a high-cost 180 patient under certain circumstances; requiring the 181 agency to submit a certain annual report to the 182 Legislature beginning on a specified date; requiring 183 that the report contain certain information; amending 184 s. 430.84, F.S.; authorizing the state administering 185 agency to exclude certain areas from designation as 186 service areas under contracts with PACE organizations 187 under certain circumstances; requiring the state to 188 determine whether a certain unmet need exists in a 189 certain area upon receipt of a letter of intent to 190 provide PACE services from a new applicant; requiring 191 such applicants to meet certain requirements; 192 requiring the agency to contract with a third-party 193 vendor to conduct a comprehensive study of nursing 194 home quality incentive programs in other states; 195 providing requirements for the study; requiring the 196 agency to submit a final report on the study to the 197 Governor and the Legislature by a specified date; 198 providing an effective date. 199 200 Be It Enacted by the Legislature of the State of Florida: 201 202 Section 1. Present subsections (5) through (10) of section 203 381.4019, Florida Statutes, are redesignated as subsections (6) 204 through (11), respectively, and a new subsection (5) is added to 205 that section, to read: 206 381.4019 Dental Student Loan Repayment Program.—The Dental 207 Student Loan Repayment Program is established to support the 208 state Medicaid program and promote access to dental care by 209 supporting qualified dentists and dental hygienists who treat 210 medically underserved populations in dental health professional 211 shortage areas or medically underserved areas. 212 (5) A dental student or dental hygiene student who 213 demonstrates an offer of employment in a public health program 214 or private practice as specified in paragraph (2)(a) may apply 215 for the loan program before obtaining active employment but may 216 not be awarded funds from the loan program until he or she meets 217 the requirements of subsection (2). 218 Section 2. Present paragraphs (c), (d), and (e) of 219 subsection (3) and present subsections (12) and (13) of section 220 381.915, Florida Statutes, are redesignated as paragraphs (d), 221 (e), and (f) of subsection (3) and subsections (13) and (14), 222 respectively, a new paragraph (c) is added to subsection (3), 223 paragraph (d) is added to subsection (10), a new subsection (12) 224 is added to that section, and paragraph (b) and present 225 paragraph (c) of subsection (3), paragraphs (a), (b), (e), (f), 226 and (h) of subsection (8), and subsections (9) and (11) of that 227 section are amended, to read: 228 381.915 Casey DeSantis Cancer Research Program.— 229 (3) On or before September 15 of each year, the department 230 shall calculate an allocation fraction to be used for 231 distributing funds to participating cancer centers. On or before 232 the final business day of each quarter of the state fiscal year, 233 the department shall distribute to each participating cancer 234 center one-fourth of that cancer center’s annual allocation 235 calculated under subsection (6). The allocation fraction for 236 each participating cancer center is based on the cancer center’s 237 tier-designated weight under subsection (4) multiplied by each 238 of the following allocation factors based on activities in this 239 state: number of reportable cases, peer-review costs, and 240 biomedical education and training. As used in this section, the 241 term: 242 (b) “Cancer center” means a comprehensive center with at 243 least one geographic site in the state, a freestanding center 244 located in the state, a center situated within an academic 245 institution, or a Florida-based formal research-based consortium 246 under centralized leadership that has achieved NCI designation 247 or is prepared to achieve NCI designation by June 30, 2024. 248 (c) “Cancer Connect Collaborative” or “collaborative” means 249 the council created under subsection (8). 250 (d)(c) “Florida-based” means that a cancer center’s actual 251 or sought designated status is or would be recognized by the NCI 252 as primarily located in Florida and not in another state, or 253 that a health care provider or facility is physically located in 254 Florida and provides services in Florida. 255 (8) The Cancer Connect Collaborative, a council as defined 256 in s. 20.03, is created within the department to advise the 257 department and the Legislature on developing a holistic approach 258 to the state’s efforts to fund cancer research, cancer 259 facilities, and treatments for cancer patients. The 260 collaborative may make recommendations on proposed legislation, 261 proposed rules, best practices, data collection and reporting, 262 issuance of grant funds, and other proposals for state policy 263 relating to cancer research or treatment. 264 (a) The Surgeon General shall serve as an ex officio, 265 nonvoting member of the collaborative and shall serve as the 266 chair. 267 (b) The collaborative shall be composed of the following 268 voting members, to be appointed by September 1, 2024: 269 1. Two members appointed by the Governor, three members one 270 member appointed by the President of the Senate, and three 271 members one member appointed by the Speaker of the House of 272 Representatives, based on the criteria of this subparagraph. The 273 appointing officers shall make their appointments prioritizing 274 members who have the following experience or expertise: 275 a. The practice of a health care profession specializing in 276 oncology clinical care or research; 277 b. The development of preventive and therapeutic treatments 278 to control cancer; 279 c. The development of innovative research into the causes 280 of cancer, the development of effective treatments for persons 281 with cancer, or cures for cancer; or 282 d. Management-level experience with a cancer center 283 licensed under chapter 395. 284 2. One member who is a resident of this state who can 285 represent the interests of cancer patients in this state, 286 appointed by the Governor. 287 (e) Members of the collaborative whose terms have expired 288 may continue to serve until replaced or reappointed, but for no 289 more than 6 months after the expiration of their terms. 290 (f) Members of the collaborative shall serve without 291 compensation but are entitled to reimbursement for per diem and 292 travel expenses pursuant to s. 112.061. 293 (h) The collaborative shall develop a long-range 294 comprehensive plan for the Casey DeSantis Cancer Research 295 Program. In the development of the plan, the collaborative must 296 solicit input from cancer centers, research institutions, 297 biomedical education institutions, hospitals, and medical 298 providers. The collaborative shall submit the plan to the 299 Governor, the President of the Senate, and the Speaker of the 300 House of Representatives no later than December 1, 2024. The 301 plan must include, but need not be limited to, all of the 302 following components: 303 1. Expansion of grant fund opportunities to include a 304 broader pool of Florida-based cancer centers, research 305 institutions, biomedical education institutions, hospitals, and 306 medical providers to receive funding through the Cancer 307 Innovation Fund. 308 2. An evaluation to determine metrics that focus on patient 309 outcomes, quality of care, and efficacy of treatment. 310 3. A compilation of best practices relating to cancer 311 research or treatment. 312 (9)(a) The collaborative shall advise the department on the 313 awarding of grants issued through the Cancer Innovation Fund. 314 During any fiscal year for which funds are appropriated to the 315 fund, the collaborative shall review all submitted grant 316 applications using the parameters provided in paragraph (c) and 317 make recommendations to the department for awarding grants to 318 support innovative cancer research and treatment models, 319 including emerging research and treatment trends and promising 320 treatments that may serve as catalysts for further research and 321 treatments. The department shall make the final grant allocation 322 awards. The collaborative shall give priority to applications 323 seeking to expand the reach of cancer screening efforts and 324 innovative cancer treatment models into underserved areas of 325 this state. 326 (b) To be eligible for grant funding under this subsection, 327 a licensed or certified health care provider, facility, or 328 entity must meet at least one of the following criteria: 329 1. Operates as a licensed hospital that has a minimum of 30 330 percent of its current cancer patients residing in rural or 331 underserved areas. 332 2. Operates as a licensed health care clinic or facility 333 that employs or contracts with at least one physician licensed 334 under chapter 458 or chapter 459 who is board certified in 335 oncology and that administers chemotherapy treatments for 336 cancer. 337 3. Operates as a licensed facility that employs or 338 contracts with at least one physician licensed under chapter 458 339 or chapter 459 who is board certified in oncology and that 340 administers radiation therapy treatments for cancer. 341 4. Operates as a licensed health care clinic or facility 342 that provides cancer screening services at no cost or a minimal 343 cost to patients. 344 5. Operates as a rural hospital as defined in s. 345 395.602(2)(b). 346 6. Operates as a critical access hospital as defined in s. 347 408.07(14). 348 7. Operates as a specialty hospital as defined in s. 349 395.002(28)(a) which provides cancer treatment for patients from 350 birth to 18 years of age. 351 8. Operates as a licensed hospital that is accredited by 352 the American College of Surgeons as a Comprehensive Community 353 Cancer Program or Integrated Network Cancer Program. 354 9. Engages in biomedical research intended to develop 355 therapies, medical pharmaceuticals, treatment protocols, or 356 medical procedures intended to cure cancer or improve the 357 quality of life of cancer patients. 358 10. Educates or trains students, postdoctoral fellows, or 359 licensed or certified health care practitioners in the 360 screening, diagnosis, or treatment of cancer. 361 (c) To ensure that all proposals for grant funding issued 362 through the Cancer Innovation Fund are appropriate and are 363 evaluated fairly on the basis of scientific merit, the 364 department shall appoint peer review panels of independent, 365 scientifically qualified individuals to review the scientific 366 merit of each proposal and establish its priority score. The 367 priority scores must be forwarded to the collaborative and must 368 be considered in determining which proposals the collaborative 369 recommends for grant funding through the Cancer Innovation Fund. 370 (d) The collaborative and the peer review panels shall 371 establish and follow rigorous guidelines for ethical conduct and 372 adhere to a strict policy with regard to conflicts of interest 373 regarding the assessment of Cancer Innovation Fund grant 374 applications. A member of the collaborative or a panel may not 375 participate in any discussion or decision of the collaborative 376 or a panel with respect to a research proposal by any firm, 377 entity, or agency with which the member is associated as a 378 member of the governing body or as an employee or with which the 379 member has entered into a contractual arrangement. 380 (e) Beginning December 1, 2025, and annually thereafter, 381 the collaborative shall prepare and submit a report to the 382 Governor, the President of the Senate, and the Speaker of the 383 House of Representatives which identifies and evaluates the 384 performance and the impact of grants issued through the Cancer 385 Innovation Fund on cancer treatment, research, screening, 386 diagnosis, prevention, practitioner training, workforce 387 education, and cancer patient survivorship. The report must 388 include all of the following: 389 1. Amounts of grant funds awarded to each recipient. 390 2. Descriptions of each recipient’s research or project 391 which include, but need not be limited to, the following: 392 a. Goals or projected outcomes. 393 b. Population to be served. 394 c. Research methods or project implementation plan. 395 3. An assessment of grant recipients which evaluates their 396 progress toward achieving objectives specified in each 397 recipient’s grant application. 398 4. Recommendations for best practices that may be 399 implemented by health care providers in this state who diagnose, 400 treat, and screen for cancer, based on the outcomes of projects 401 funded through the Cancer Innovation Fund. 402 (10) Beginning July 1, 2025, and each year thereafter, the 403 department, in conjunction with participating cancer centers, 404 shall submit a report to the Cancer Control and Research 405 Advisory Council and the collaborative on specific metrics 406 relating to cancer mortality and external funding for cancer 407 related research in this state. If a cancer center does not 408 endorse this report or produce an equivalent independent report, 409 the cancer center is ineligible to receive program funding for 1 410 year. The department must submit this annual report, and any 411 equivalent independent reports, to the Governor, the President 412 of the Senate, and the Speaker of the House of Representatives 413 no later than September 15 of each year the report or reports 414 are submitted by the department. The report must include: 415 (d) A description of the numbers and types of cancer cases 416 treated annually at each participating cancer center, including 417 reportable and nonreportable cases. 418 (11) Beginning July 1, 2025 2024, each allocation agreement 419 issued by the department relating to cancer center payments 420 under paragraph (2)(a) subsection (2) must include all of the 421 following: 422 (a) A line-item budget narrative documenting the annual 423 allocation of funds to a cancer center. 424 (b) A cap on the annual award of 15 percent for 425 administrative expenses. 426 (c) A requirement for the cancer center to submit quarterly 427 reports of all expenditures made by the cancer center with funds 428 received through the Casey DeSantis Cancer Research Program. 429 (d) A provision to allow the department and other state 430 auditing bodies to audit all financial records, supporting 431 documents, statistical records, and any other documents 432 pertinent to the allocation agreement. 433 (e) A provision requiring the annual reporting of outcome 434 data and protocols used in achieving those outcomes. 435 (12)(a) The Legislature finds that targeted areas of cancer 436 research require increased resources and that Florida should 437 become a leader in promoting research opportunities for these 438 targeted areas. Floridians should not have to leave the state to 439 receive the most advanced cancer care and treatment. To meet 440 this need, the Cancer Connect Collaborative Research Incubator, 441 or “incubator” as used in this subsection, is created within the 442 department, to be overseen by the collaborative, to provide 443 funding for a targeted area of cancer research over a 5-year 444 period. For the 5-year period beginning July 1, 2025, the 445 incubator’s targeted area of cancer research is pediatric 446 cancer. 447 (b) Contingent upon the appropriation of funds by the 448 Legislature, grants issued through the incubator must be awarded 449 through a peer-reviewed, competitive process. Priority must be 450 given to applicants that focus on enhancing both research and 451 treatment by increasing participation in clinical trials related 452 to the targeted area of cancer research, including all of the 453 following: 454 1. Identifying strategies to increase enrollment in cancer 455 clinical trials. 456 2. Supporting public and private professional education 457 programs to raise awareness and knowledge about cancer clinical 458 trials. 459 3. Providing tools for cancer patients and community-based 460 oncologists to help identify available cancer clinical trials in 461 this state. 462 4. Creating opportunities for the state’s academic cancer 463 centers to collaborate with community-based oncologists in 464 cancer clinical trial networks. 465 (c) Priority may be given to grant proposals that foster 466 collaborations among institutions, researchers, and community 467 practitioners to support the advancement of cures through basic 468 or applied research, including clinical trials involving cancer 469 patients and related networks. 470 (d) Applications for incubator funding may be submitted by 471 any Florida-based specialty hospital as defined in s. 472 395.002(28)(a) which provides cancer treatment for patients from 473 birth to 18 years of age. All qualified applicants must have 474 equal access and opportunity to compete for research funding. 475 Incubator grants must be recommended by the collaborative and 476 awarded by the department on the basis of scientific merit, as 477 determined by a competitively open and peer-reviewed process to 478 ensure objectivity, consistency, and high quality. 479 (e) To ensure that all proposals for research funding are 480 appropriate and are evaluated fairly on the basis of scientific 481 merit, the department shall appoint peer review panels of 482 independent, scientifically qualified individuals to review the 483 scientific merit of each proposal and establish its priority 484 score. The priority scores must be forwarded to the 485 collaborative and must be considered in determining which 486 proposals the collaborative recommends for funding. 487 (f) The collaborative and the peer review panels shall 488 establish and follow rigorous guidelines for ethical conduct and 489 adhere to a strict policy with regard to conflicts of interest 490 regarding the assessment of incubator grant applications. A 491 member of the collaborative or a panel may not participate in 492 any discussion or decision of the collaborative or a panel 493 regarding a research proposal from any firm, entity, or agency 494 with which the member is associated as a governing body member, 495 as an employee, or through a contractual arrangement. 496 (g) Each recipient of incubator grant funds must enter into 497 an allocation agreement with the department. Each such 498 allocation agreement must include all of the following: 499 1. A line-item budget narrative documenting the annual 500 allocation of funds to a recipient. 501 2. A cap on the annual award of 15 percent for 502 administrative expenses. 503 3. A requirement for the recipient to submit quarterly 504 reports of all expenditures made by the recipient with funds 505 received through the incubator. 506 4. A provision to allow the department and other state 507 auditing bodies to audit all financial records, supporting 508 documents, statistical records, and any other documents 509 pertinent to the allocation agreement. 510 5. A provision requiring the annual reporting of outcome 511 data and protocols used in achieving those outcomes. 512 (h) Beginning December 1, 2026, and annually through 513 December 1, 2030, the collaborative shall prepare and submit a 514 report to the Governor, the President of the Senate, and the 515 Speaker of the House of Representatives which evaluates research 516 conducted through the incubator and provides details on outcomes 517 and findings available through the end of the fiscal year 518 immediately preceding each report. If the collaborative 519 recommends that the incubator be extended beyond its 5-year 520 lifespan, the collaborative shall make such recommendation in 521 the report due December 1, 2029, and shall include a 522 recommendation for the next targeted area of cancer research. 523 The report due on December 1, 2030, must include all of the 524 following: 525 1. Details of all results of the research conducted with 526 incubator funding which has been completed or the status of 527 research in progress. 528 2. An evaluation of all research conducted with incubator 529 funding during the 5 fiscal years preceding the report. 530 Section 3. Paragraph (d) is added to subsection (2) of 531 section 381.922, Florida Statutes, to read: 532 381.922 William G. “Bill” Bankhead, Jr., and David Coley 533 Cancer Research Program.— 534 (2) The program shall provide grants for cancer research to 535 further the search for cures for cancer. 536 (d) There is established within the program the Bascom 537 Palmer Eye Institute VisionGen Initiative. The purpose of the 538 initiative is to advance genetic and epigenetic research on 539 inherited eye diseases and ocular oncology by awarding grants 540 through the peer-reviewed, competitive process established under 541 subsection (3). Funding for the initiative is subject to the 542 annual appropriation of funds by the Legislature. 543 Section 4. Paragraphs (d) and (e) of subsection (5) of 544 section 381.986, Florida Statutes, are amended to read: 545 381.986 Medical use of marijuana.— 546 (5) MEDICAL MARIJUANA USE REGISTRY.— 547 (d) The department shall immediately suspend the 548 registration of a qualified patient charged with a violation of 549 chapter 893 until final disposition of the any alleged offense. 550 Based upon such final disposition Thereafter, the department may 551 extend the suspension, revoke the registration, or reinstate the 552 registration. However, the department must revoke the 553 registration of the qualified patient upon such final 554 disposition if the qualified patient was convicted of, or pled 555 guilty or nolo contendere to, regardless of adjudication, a 556 violation of chapter 893 if such violation was for trafficking 557 in, the sale, manufacture, or delivery of, or possession with 558 intent to sell, manufacture, or deliver a controlled substance. 559 If such person wishes to seek reinstatement of his or her 560 registration as a qualified patient, the person may submit a new 561 application accompanied by a notarized attestation by the 562 applicant that he or she has completed all terms of 563 incarceration, probation, community control, or supervision 564 related to the offense. A person who knowingly makes a false 565 attestation under this paragraph commits a misdemeanor of the 566 second degree, punishable as provided in s. 775.082 or s. 567 775.083. 568 (e) The department shall immediately suspend the 569 registration of a any caregiver charged with a violation of 570 chapter 893 until final disposition of the any alleged offense. 571 The department must revoke the registration of the caregiver 572 upon such final disposition if the caregiver was convicted of, 573 or pled guilty or nolo contendere to, regardless of 574 adjudication, a violation of chapter 893 if such violation was 575 for trafficking in, the sale, manufacture, or delivery of, or 576 possession with intent to sell, manufacture, or deliver a 577 controlled substance. If such person wishes to seek 578 reinstatement of his or her registration as a caregiver, the 579 person may submit a new application accompanied by a notarized 580 attestation by the applicant that he or she has completed all 581 terms of incarceration, probation, community control, or 582 supervision related to the offense. A person who knowingly makes 583 a false attestation under this paragraph commits a misdemeanor 584 of the second degree, punishable as provided in s. 775.082 or s. 585 775.083. Additionally, the department must shall revoke a 586 caregiver registration if the caregiver does not meet the 587 requirements of subparagraph (6)(b)6. 588 Section 5. Notwithstanding the repeal of section 400.0225, 589 Florida Statutes, in section 14 of chapter 2001-377, Laws of 590 Florida, that section is revived, reenacted, and amended to 591 read: 592 400.0225 Consumer satisfaction surveys.— 593 (1) The agency shall develop user-friendly consumer 594 satisfaction surveys to capture resident and family member 595 satisfaction with care provided by nursing home facilities. The 596 consumer satisfaction surveys must be based on a core set of 597 consumer satisfaction questions to allow for consistent 598 measurement and must be administered annually to a random sample 599 of long-stay and short-stay residents of each facility and their 600 family members. The survey tool must be based on an agency 601 validated survey instrument whose measures have received an 602 endorsement by the National Quality Forum. 603 (2) Family members, guardians, or other resident designees 604 may assist a resident in completing the consumer satisfaction 605 survey. 606 (3) Employees and volunteers of the nursing home facility 607 or of a corporation or business entity with an ownership 608 interest in the nursing home facility are prohibited from 609 attempting to influence a resident’s responses to the consumer 610 satisfaction survey. 611 (4) The agency shall specify the protocols for conducting 612 the consumer satisfaction surveys, ensuring survey validity, 613 reporting survey results, and protecting the identity of 614 individual respondents. The agency shall make aggregated survey 615 data available to consumers on the agency’s website pursuant to 616 s. 400.191(2)(a)15. in a manner that allows for comparison 617 between nursing home facilities, or its contractor, in 618 consultation with the nursing home industry and consumer 619 representatives, shall develop an easy-to-use consumer 620 satisfaction survey, shall ensure that every nursing facility 621 licensed pursuant to this part participates in assessing 622 consumer satisfaction, and shall establish procedures to ensure 623 that, at least annually, a representative sample of residents of 624 each facility is selected to participate in the survey. The 625 sample shall be of sufficient size to allow comparisons between 626 and among facilities. Family members, guardians, or other 627 resident designees may assist the resident in completing the 628 survey. Employees and volunteers of the nursing facility or of a 629 corporation or business entity with an ownership interest in the 630 facility are prohibited from assisting a resident with or 631 attempting to influence a resident’s responses to the consumer 632 satisfaction survey. The agency, or its contractor, shall survey 633 family members, guardians, or other resident designees. The 634 agency, or its contractor, shall specify the protocol for 635 conducting and reporting the consumer satisfaction surveys. 636 Reports of consumer satisfaction surveys shall protect the 637 identity of individual respondents. The agency shall contract 638 for consumer satisfaction surveys and report the results of 639 those surveys in the consumer information materials prepared and 640 distributed by the agency. 641 (5) The agency may adopt rules as necessary to implement 642 administer this section. 643 Section 6. Paragraph (b) of subsection (1) of section 644 400.141, Florida Statutes, is amended, and paragraph (x) is 645 added to that subsection, to read: 646 400.141 Administration and management of nursing home 647 facilities.— 648 (1) Every licensed facility shall comply with all 649 applicable standards and rules of the agency and shall: 650 (b) Appoint a medical director licensed pursuant to chapter 651 458 or chapter 459. By January 1, 2026, the medical director of 652 each nursing home facility must obtain designation as a 653 certified medical director by the American Medical Directors 654 Association, hold a similar credential bestowed by an 655 organization recognized by the agency, or be in the process of 656 seeking such designation or credentialing, according to 657 parameters adopted by agency rule. The agency shall include the 658 name of each nursing home facility’s medical director on the 659 facility’s provider profile published by the agency on its 660 website. The agency may establish by rule more specific criteria 661 for the appointment of a medical director. 662 (x) Conduct, at least biennially, a patient safety culture 663 survey using the applicable Survey on Patient Safety Culture 664 developed by the federal Agency for Healthcare Research and 665 Quality. Each facility shall conduct the survey anonymously to 666 encourage completion of the survey by staff working in or 667 employed by the facility. A facility may contract with a third 668 party to administer the survey. Each facility shall biennially 669 submit the survey data to the agency in a format specified by 670 agency rule, which must include the survey participation rate. 671 Each facility may develop an internal action plan between 672 conducting surveys to identify measures to improve the survey 673 and submit such plan to the agency. 674 Section 7. Paragraph (a) of subsection (2) of section 675 400.191, Florida Statutes, is amended to read: 676 400.191 Availability, distribution, and posting of reports 677 and records.— 678 (2) The agency shall publish the Nursing Home Guide 679 quarterly in electronic form to assist consumers and their 680 families in comparing and evaluating nursing home facilities. 681 (a) The agency shall provide an Internet site which must 682 shall include at least the following information either directly 683 or indirectly through a link to another established site or 684 sites of the agency’s choosing: 685 1. A section entitled “Have you considered programs that 686 provide alternatives to nursing home care?” which must shall be 687 the first section of the Nursing Home Guide and must which shall 688 prominently display information about available alternatives to 689 nursing homes and how to obtain additional information regarding 690 these alternatives. The Nursing Home Guide must shall explain 691 that this state offers alternative programs that allow permit 692 qualified elderly persons to stay in their homes instead of 693 being placed in nursing homes and must shall encourage 694 interested persons to call the Comprehensive Assessment Review 695 and Evaluation for Long-Term Care Services (CARES) Program to 696 inquire as to whether if they qualify. The Nursing Home Guide 697 must shall list available home and community-based programs and 698 must which shall clearly state the services that are provided, 699 including and indicate whether nursing home services are covered 700 under those programs when necessary included if needed. 701 2. A list by name and address of all nursing home 702 facilities in this state, including any prior name by which a 703 facility was known during the previous 24-month period. 704 3. Whether such nursing home facilities are proprietary or 705 nonproprietary. 706 4. The current owner of the facility’s license and the year 707 that that entity became the owner of the license. 708 5. The name of the owner or owners of each facility and 709 whether the facility is affiliated with a company or other 710 organization owning or managing more than one nursing facility 711 in this state. 712 6. The total number of beds in each facility and the most 713 recently available occupancy levels. 714 7. The number of private and semiprivate rooms in each 715 facility. 716 8. The religious affiliation, if any, of each facility. 717 9. The languages spoken by the administrator and staff of 718 each facility. 719 10. Whether or not each facility accepts Medicare or 720 Medicaid recipients or insurance, health maintenance 721 organization, United States Department of Veterans Affairs, 722 CHAMPUS program, or workers’ compensation coverage. 723 11. Recreational and other programs available at each 724 facility. 725 12. Special care units or programs offered at each 726 facility. 727 13. Whether the facility is a part of a retirement 728 community that offers other services pursuant to part III of 729 this chapter or part I or part III of chapter 429. 730 14. Survey and deficiency information, including all 731 federal and state recertification, licensure, revisit, and 732 complaint survey information, for each facility. For 733 noncertified nursing homes, state survey and deficiency 734 information, including licensure, revisit, and complaint survey 735 information, shall be provided. 736 15. The results of consumer satisfaction surveys conducted 737 pursuant to s. 400.0225. 738 Section 8. Present subsections (6) and (7) of section 739 408.051, Florida Statutes, are redesignated as subsections (7) 740 and (8), respectively, and a new subsection (6) is added to that 741 section, to read: 742 408.051 Florida Electronic Health Records Exchange Act.— 743 (6) NURSING HOME DATA.—A nursing home facility as defined 744 in s. 400.021 which maintains certified electronic health record 745 technology shall make available all admission, transfer, and 746 discharge data to the agency’s Florida Health Information 747 Exchange program for the purpose of supporting public health 748 data registries and patient care coordination. The agency may 749 adopt rules to implement this subsection. 750 Section 9. Present subsections (7) through (15) of section 751 408.061, Florida Statutes, are redesignated as subsections (8) 752 through (16), respectively, a new subsection (7) is added to 753 that section, and subsections (5) and (6) of that section are 754 amended, to read: 755 408.061 Data collection; uniform systems of financial 756 reporting; information relating to physician charges; 757 confidential information; immunity.— 758 (5) Within 120 days after the end of its fiscal year, each 759 nursing home as defined in s. 408.07, excluding nursing homes 760 operated by state agencies, shall file with the agency, on forms 761 adopted by the agency and based on the uniform system of 762 financial reporting, its actual financial experience for that 763 fiscal year, including expenditures, revenues, and statistical 764 measures. Such data may be based on internal financial reports 765 that are certified to be complete and accurate by the chief 766 financial officer of the nursing home. However, a nursing home’s 767 actual financial experience shall be its audited actual 768 experience. This audited actual experience must include the 769 fiscal year-end balance sheet, income statement, statement of 770 cash flow, and statement of retained earnings and must be 771 submitted to the agency in addition to the information filed in 772 the uniform system of financial reporting. The financial 773 statements must tie to the information submitted in the uniform 774 system of financial reporting, and a crosswalk must be submitted 775 along with the financial statements. 776 (6) Within 120 days after the end of its fiscal year, the 777 home office of each nursing home as defined in s. 408.07, 778 excluding nursing homes operated by state agencies, shall file 779 with the agency, on forms adopted by the agency and based on the 780 uniform system of financial reporting, its actual financial 781 experience for that fiscal year, including expenditures, 782 revenues, and statistical measures. Such data may be based on 783 internal financial reports that are certified to be complete and 784 accurate by the chief financial officer of the nursing home. 785 However, the home office’s actual financial experience shall be 786 its audited actual experience. This audited actual experience 787 must include the fiscal year-end balance sheet, income 788 statement, statement of cash flow, and statement of retained 789 earnings and must be submitted to the agency in addition to the 790 information filed in the uniform system of financial reporting. 791 The financial statements must tie to the information submitted 792 in the uniform system of financial reporting, and a crosswalk 793 must be submitted along with the audited financial statements. 794 (7)(a) Beginning January 1, 2026, the agency shall impose 795 an administrative fine of $10,000 per violation against a 796 nursing home or home office that fails to comply with subsection 797 (5) or subsection (6), as applicable. For purposes of this 798 paragraph, the term “violation” means failing to file the 799 financial report required by subsection (5) or subsection (6), 800 as applicable, on or before the report’s due date. Failing to 801 file the report during any subsequent 10-day period occurring 802 after the due date constitutes a separate violation until the 803 report has been submitted. 804 (b) The agency shall adopt rules to implement this 805 subsection. The rules must include provisions for a nursing home 806 or home office to present factors in mitigation of the 807 imposition of the fine’s full dollar amount. The agency may 808 determine not to impose the fine’s full dollar amount upon a 809 showing that the full fine is inappropriate under the 810 circumstances. 811 Section 10. Subsection (2) of section 408.08, Florida 812 Statutes, is amended to read: 813 408.08 Inspections and audits; violations; penalties; 814 fines; enforcement.— 815 (2) Any health care facility that refuses to file a report, 816 fails to timely file a report, files a false report, or files an 817 incomplete report and upon notification fails to timely file a 818 complete report required under s. 408.061; that violates this 819 section, s. 408.061, or s. 408.20, or rule adopted thereunder; 820 or that fails to provide documents or records requested by the 821 agency under this chapter shall be punished by a fine not 822 exceeding $1,000 per day for each day in violation, to be 823 imposed and collected by the agency. Pursuant to rules adopted 824 by the agency, the agency may, upon a showing of good cause, 825 grant a one-time extension of any deadline for a health care 826 facility to timely file a report as required by this section, s. 827 408.061, or s. 408.20. A facility fined under s. 408.061(7) may 828 not be additionally fined under this subsection for the same 829 violation. 830 Section 11. Subsection (1) of section 409.904, Florida 831 Statutes, is amended to read: 832 409.904 Optional payments for eligible persons.—The agency 833 may make payments for medical assistance and related services on 834 behalf of the following persons who are determined to be 835 eligible subject to the income, assets, and categorical 836 eligibility tests set forth in federal and state law. Payment on 837 behalf of these Medicaid eligible persons is subject to the 838 availability of moneys and any limitations established by the 839 General Appropriations Act or chapter 216. 840 (1)(a) Subject to federal waiver approval, a person who is 841 age 65 or older or is determined to be disabled, whose income is 842 at or below 88 percent of the federal poverty level, whose 843 assets do not exceed established limitations, and who is not 844 eligible for Medicare or, if eligible for Medicare, is also 845 eligible for and receiving Medicaid-covered institutional care 846 services, hospice services, or home and community-based 847 services. The agency shall seek federal authorization through a 848 waiver to provide this coverage. 849 (b)1. A person who was initially determined eligible for 850 Medicaid under paragraph (a) and is receiving Medicaid-covered 851 institutional care services or hospice services, or a person who 852 is receiving home and community-based services pursuant to s. 853 393.066 or s. 409.978, shall be presumed eligible for continued 854 coverage for such Medicaid-covered services during any 855 redetermination process, and the agency shall continue to make 856 payments for such services, unless the person experiences a 857 material change in his or her disability or economic status 858 which results in a loss of eligibility. In the event of such a 859 change in disability or economic status, the person or his or 860 her designated caregiver or responsible party must notify the 861 agency and the Department of Children and Families of such 862 change, and the department may conduct a redetermination of 863 eligibility. If such redetermination is conducted, the 864 department must notify the person or his or her designated 865 caregiver or responsible party before the commencement of the 866 redetermination and, at its conclusion, the results of the 867 redetermination. 868 2. The agency shall, no later than October 1, 2025, seek 869 federal authorization to exempt a Medicaid-eligible disabled 870 person from annual redetermination of eligibility pursuant to 871 this paragraph. 872 3. The agency and the department shall develop a process to 873 facilitate the notifications required under subparagraph 1. 874 Section 12. Paragraph (d) of subsection (29) of section 875 409.906, Florida Statutes, is amended to read: 876 409.906 Optional Medicaid services.—Subject to specific 877 appropriations, the agency may make payments for services which 878 are optional to the state under Title XIX of the Social Security 879 Act and are furnished by Medicaid providers to recipients who 880 are determined to be eligible on the dates on which the services 881 were provided. Any optional service that is provided shall be 882 provided only when medically necessary and in accordance with 883 state and federal law. Optional services rendered by providers 884 in mobile units to Medicaid recipients may be restricted or 885 prohibited by the agency. Nothing in this section shall be 886 construed to prevent or limit the agency from adjusting fees, 887 reimbursement rates, lengths of stay, number of visits, or 888 number of services, or making any other adjustments necessary to 889 comply with the availability of moneys and any limitations or 890 directions provided for in the General Appropriations Act or 891 chapter 216. If necessary to safeguard the state’s systems of 892 providing services to elderly and disabled persons and subject 893 to the notice and review provisions of s. 216.177, the Governor 894 may direct the Agency for Health Care Administration to amend 895 the Medicaid state plan to delete the optional Medicaid service 896 known as “Intermediate Care Facilities for the Developmentally 897 Disabled.” Optional services may include: 898 (29) BIOMARKER TESTING SERVICES.— 899 (d) This subsection does not require coverage of biomarker 900 testing for screening purposes. The agency may pay for blood 901 based biomarker tests at an in-network or out-of-network 902 laboratory facility for colorectal cancer screening covered 903 under a National Coverage Determination from the Centers for 904 Medicare and Medicaid Services. 905 Section 13. Paragraph (b) of subsection (2) of section 906 409.908, Florida Statutes, is amended to read: 907 409.908 Reimbursement of Medicaid providers.—Subject to 908 specific appropriations, the agency shall reimburse Medicaid 909 providers, in accordance with state and federal law, according 910 to methodologies set forth in the rules of the agency and in 911 policy manuals and handbooks incorporated by reference therein. 912 These methodologies may include fee schedules, reimbursement 913 methods based on cost reporting, negotiated fees, competitive 914 bidding pursuant to s. 287.057, and other mechanisms the agency 915 considers efficient and effective for purchasing services or 916 goods on behalf of recipients. If a provider is reimbursed based 917 on cost reporting and submits a cost report late and that cost 918 report would have been used to set a lower reimbursement rate 919 for a rate semester, then the provider’s rate for that semester 920 shall be retroactively calculated using the new cost report, and 921 full payment at the recalculated rate shall be effected 922 retroactively. Medicare-granted extensions for filing cost 923 reports, if applicable, shall also apply to Medicaid cost 924 reports. Payment for Medicaid compensable services made on 925 behalf of Medicaid-eligible persons is subject to the 926 availability of moneys and any limitations or directions 927 provided for in the General Appropriations Act or chapter 216. 928 Further, nothing in this section shall be construed to prevent 929 or limit the agency from adjusting fees, reimbursement rates, 930 lengths of stay, number of visits, or number of services, or 931 making any other adjustments necessary to comply with the 932 availability of moneys and any limitations or directions 933 provided for in the General Appropriations Act, provided the 934 adjustment is consistent with legislative intent. 935 (2) 936 (b) Subject to any limitations or directions in the General 937 Appropriations Act, the agency shall establish and implement a 938 state Title XIX Long-Term Care Reimbursement Plan for nursing 939 home care in order to provide care and services in conformance 940 with the applicable state and federal laws, rules, regulations, 941 and quality and safety standards and to ensure that individuals 942 eligible for medical assistance have reasonable geographic 943 access to such care. 944 1. The agency shall amend the long-term care reimbursement 945 plan and cost reporting system to create direct care and 946 indirect care subcomponents of the patient care component of the 947 per diem rate. These two subcomponents together shall equal the 948 patient care component of the per diem rate. Separate prices 949 shall be calculated for each patient care subcomponent, 950 initially based on the September 2016 rate setting cost reports 951 and subsequently based on the most recently audited cost report 952 used during a rebasing year. The direct care subcomponent of the 953 per diem rate for any providers still being reimbursed on a cost 954 basis shall be limited by the cost-based class ceiling, and the 955 indirect care subcomponent may be limited by the lower of the 956 cost-based class ceiling, the target rate class ceiling, or the 957 individual provider target. The ceilings and targets apply only 958 to providers being reimbursed on a cost-based system. Effective 959 October 1, 2018, a prospective payment methodology shall be 960 implemented for rate setting purposes with the following 961 parameters: 962 a. Peer Groups, including: 963 (I) North-SMMC Regions 1-9, less Palm Beach and Okeechobee 964 Counties; and 965 (II) South-SMMC Regions 10-11, plus Palm Beach and 966 Okeechobee Counties. 967 b. Percentage of Median Costs based on the cost reports 968 used for September 2016 rate setting: 969 (I) Direct Care Costs........................100 percent. 970 (II) Indirect Care Costs......................92 percent. 971 (III) Operating Costs.........................86 percent. 972 c. Floors: 973 (I) Direct Care Component.....................95 percent. 974 (II) Indirect Care Component................92.5 percent. 975 (III) Operating Component...........................None. 976 d. Pass-through Payments..................Real Estate and 977 ...............................................Personal Property 978 ...................................Taxes and Property Insurance. 979 e. Quality Incentive Program Payment 980 Pool.....................................10 percent of September 981 .......................................2016 non-property related 982 ................................payments of included facilities. 983 f. Quality Score Threshold to Qualify Quality for Quality 984 Incentive Payment...........................................20th 985 ..............................percentile of included facilities. 986 g. Fair Rental Value System Payment Parameters: 987 (I) Building Value per Square Foot based on 2018 RS Means. 988 (II) Land Valuation...10 percent of Gross Building value. 989 (III) Facility Square Footage......Actual Square Footage. 990 (IV) Movable Equipment Allowance..........$8,000 per bed. 991 (V) Obsolescence Factor......................1.5 percent. 992 (VI) Fair Rental Rate of Return................8 percent. 993 (VII) Minimum Occupancy.......................90 percent. 994 (VIII) Maximum Facility Age.....................40 years. 995 (IX) Minimum Square Footage per Bed..................350. 996 (X) Maximum Square Footage for Bed...................500. 997 (XI) Minimum Cost of a renovation/replacements$500 per bed. 998 h. Ventilator Supplemental payment of $200 per Medicaid day 999 of 40,000 ventilator Medicaid days per fiscal year. 1000 2. The agency shall revise its methodology for calculating 1001 Quality Incentive Program payments to include the results of 1002 consumer satisfaction surveys conducted pursuant to s. 400.0225 1003 as a measure of nursing home quality. The agency shall so revise 1004 the methodology after the surveys have been in effect for an 1005 amount of time the agency deems sufficient for statistical and 1006 scientific validity as a meaningful quality measure that may be 1007 incorporated into the methodology. 1008 3. The direct care subcomponent shall include salaries and 1009 benefits of direct care staff providing nursing services 1010 including registered nurses, licensed practical nurses, and 1011 certified nursing assistants who deliver care directly to 1012 residents in the nursing home facility, allowable therapy costs, 1013 and dietary costs. This excludes nursing administration, staff 1014 development, the staffing coordinator, and the administrative 1015 portion of the minimum data set and care plan coordinators. The 1016 direct care subcomponent also includes medically necessary 1017 dental care, vision care, hearing care, and podiatric care. 1018 4.3. All other patient care costs shall be included in the 1019 indirect care cost subcomponent of the patient care per diem 1020 rate, including complex medical equipment, medical supplies, and 1021 other allowable ancillary costs. Costs may not be allocated 1022 directly or indirectly to the direct care subcomponent from a 1023 home office or management company. 1024 5.4. On July 1 of each year, the agency shall report to the 1025 Legislature direct and indirect care costs, including average 1026 direct and indirect care costs per resident per facility and 1027 direct care and indirect care salaries and benefits per category 1028 of staff member per facility. 1029 6.5. Every fourth year, the agency shall rebase nursing 1030 home prospective payment rates to reflect changes in cost based 1031 on the most recently audited cost report for each participating 1032 provider. 1033 7.6. A direct care supplemental payment may be made to 1034 providers whose direct care hours per patient day are above the 1035 80th percentile and who provide Medicaid services to a larger 1036 percentage of Medicaid patients than the state average. 1037 8.7. Pediatric, Florida Department of Veterans Affairs, and 1038 government-owned facilities are exempt from the pricing model 1039 established in this subsection and shall remain on a cost-based 1040 prospective payment system. Effective October 1, 2018, the 1041 agency shall set rates for all facilities remaining on a cost 1042 based prospective payment system using each facility’s most 1043 recently audited cost report, eliminating retroactive 1044 settlements. 1045 9. By October 1, 2025, and each year thereafter, the agency 1046 shall submit to the Governor, the President of the Senate, and 1047 the Speaker of the House of Representatives a report on each 1048 Quality Incentive Program payment made pursuant to sub 1049 subparagraph 1.e. The report must, at a minimum, include all of 1050 the following information: 1051 a. The name of each facility that received a Quality 1052 Incentive Program payment and the dollar amount of such payment 1053 each facility received. 1054 b. The total number of quality incentive metric points 1055 awarded by the agency to each facility and the number of points 1056 awarded by the agency for each individual quality metric 1057 measured. 1058 c. An examination of any trends in the improvement of the 1059 quality of care provided to nursing home residents which may be 1060 attributable to incentive payments received under the Quality 1061 Incentive Program. The agency shall include examination of 1062 trends both for the program as a whole as well as for each 1063 individual quality metric used by the agency to award program 1064 payments. 1065 1066 It is the intent of the Legislature that the reimbursement plan 1067 achieve the goal of providing access to health care for nursing 1068 home residents who require large amounts of care while 1069 encouraging diversion services as an alternative to nursing home 1070 care for residents who can be served within the community. The 1071 agency shall base the establishment of any maximum rate of 1072 payment, whether overall or component, on the available moneys 1073 as provided for in the General Appropriations Act. The agency 1074 may base the maximum rate of payment on the results of 1075 scientifically valid analysis and conclusions derived from 1076 objective statistical data pertinent to the particular maximum 1077 rate of payment. The agency shall base the rates of payments in 1078 accordance with the minimum wage requirements as provided in the 1079 General Appropriations Act. 1080 Section 14. Present subsection (10) of section 409.909, 1081 Florida Statutes, as amended by section 5 of chapter 2024-12, 1082 Laws of Florida, is redesignated as subsection (9), and 1083 paragraph (a) of subsection (6) and present subsection (9) of 1084 that section are amended, to read: 1085 409.909 Statewide Medicaid Residency Program.— 1086 (6) The Slots for Doctors Program is established to address 1087 the physician workforce shortage by increasing the supply of 1088 highly trained physicians through the creation of new resident 1089 positions, which will increase access to care and improve health 1090 outcomes for Medicaid recipients. 1091 (a)1. Notwithstanding subsection (4), the agency shall 1092 annually allocate $100,000 to hospitals, qualifying 1093 institutions, and behavioral health teaching hospitals 1094 designated under s. 395.902, for each newly created resident 1095 position that is first filled on or after June 1, 2023, and 1096 filled thereafter, and that is accredited by the Accreditation 1097 Council for Graduate Medical Education or the Osteopathic 1098 Postdoctoral Training Institution in an initial or established 1099 accredited training program which is in a physician specialty or 1100 subspecialty in a statewide supply-and-demand deficit. 1101 2. Notwithstanding the requirement that a new resident 1102 position be created to receive funding under this subsection, 1103 the agency may allocate $100,000 to hospitals and qualifying 1104 institutions, pursuant to subparagraph 1., for up to 100 200 1105 resident positions that existed before July 1, 2023, if such 1106 resident position: 1107 a. Is in a physician specialty or subspecialty experiencing 1108 a statewide supply-and-demand deficit; 1109 b. Has been unfilled for a period of 3 or more years; 1110 c. Is subsequently filled on or after June 1, 2024, and 1111 remains filled thereafter; and 1112 d. Is accredited by the Accreditation Council for Graduate 1113 Medical Education or the Osteopathic Postdoctoral Training 1114 Institution in an initial or established accredited training 1115 program. 1116 3. If applications for resident positions under this 1117 paragraph exceed the number of authorized resident positions or 1118 the available funding allocated, the agency shall prioritize 1119 applications for resident positions that are in a primary care 1120 specialty as specified in paragraph (2)(a). 1121 (9) The Graduate Medical Education Committee is created 1122 within the agency. 1123 (a) The committee shall be composed of the following 1124 members: 1125 1. Three deans, or their designees, from medical schools in 1126 this state, appointed by the chair of the Council of Florida 1127 Medical School Deans. 1128 2. Four members appointed by the Governor, one of whom is a 1129 representative of the Florida Medical Association or the Florida 1130 Osteopathic Medical Association who has supervised or is 1131 currently supervising residents, one of whom is a member of the 1132 Florida Hospital Association, one of whom is a member of the 1133 Safety Net Hospital Alliance, and one of whom is a physician 1134 licensed under chapter 458 or chapter 459 practicing at a 1135 qualifying institution. 1136 3. Two members appointed by the Secretary of Health Care 1137 Administration, one of whom represents a statutory teaching 1138 hospital as defined in s. 408.07(46) and one of whom is a 1139 physician who has supervised or is currently supervising 1140 residents. 1141 4. Two members appointed by the State Surgeon General, one 1142 of whom must represent a teaching hospital as defined in s. 1143 408.07 and one of whom is a physician who has supervised or is 1144 currently supervising residents or interns. 1145 5. Two members, one appointed by the President of the 1146 Senate and one appointed by the Speaker of the House of 1147 Representatives. 1148 (b)1. The members of the committee appointed under 1149 subparagraph (a)1. shall serve 4-year terms. When such members’ 1150 terms expire, the chair of the Council of Florida Medical School 1151 Deans shall appoint new members as detailed in subparagraph 1152 (a)1. from different medical schools on a rotating basis and may 1153 not reappoint a dean from a medical school that has been 1154 represented on the committee until all medical schools in the 1155 state have had an opportunity to be represented on the 1156 committee. 1157 2. The members of the committee appointed under 1158 subparagraphs (a)2.-4. shall serve 4-year terms, with the 1159 initial term being 3 years for members appointed under 1160 subparagraph (a)4. and 2 years for members appointed under 1161 subparagraph (a)3. The committee shall elect a chair to serve 1162 for a 1-year term. 1163 (c) Members shall serve without compensation but are 1164 entitled to reimbursement for per diem and travel expenses 1165 pursuant to s. 112.061. 1166 (d) The committee shall convene its first meeting by July 1167 1, 2024, and shall meet as often as necessary to conduct its 1168 business, but at least twice annually, at the call of the chair. 1169 The committee may conduct its meetings through teleconference or 1170 other electronic means. A majority of the members of the 1171 committee constitutes a quorum, and a meeting may not be held 1172 with less than a quorum present. The affirmative vote of a 1173 majority of the members of the committee present is necessary 1174 for any official action by the committee. 1175 (e) Beginning on July 1, 2025, the committee shall submit 1176 an annual report to the Governor, the President of the Senate, 1177 and the Speaker of the House of Representatives which must, at a 1178 minimum, detail all of the following: 1179 1. The role of residents and medical faculty in the 1180 provision of health care. 1181 2. The relationship of graduate medical education to the 1182 state’s physician workforce. 1183 3. The typical workload for residents and the role such 1184 workload plays in retaining physicians in the long-term 1185 workforce. 1186 4. The costs of training medical residents for hospitals 1187 and qualifying institutions. 1188 5. The availability and adequacy of all sources of revenue 1189 available to support graduate medical education. 1190 6. The use of state funds, including, but not limited to, 1191 intergovernmental transfers, for graduate medical education for 1192 each hospital or qualifying institution receiving such funds. 1193 (f) The agency shall provide reasonable and necessary 1194 support staff and materials to assist the committee in the 1195 performance of its duties. The agency shall also provide the 1196 information obtained pursuant to subsection (8) to the committee 1197 and assist the committee, as requested, in obtaining any other 1198 information deemed necessary by the committee to produce its 1199 report. 1200 Section 15. Subsection (1), paragraph (d) of subsection 1201 (2), and paragraph (a) of subsection (5) of section 409.91256, 1202 Florida Statutes, are amended to read: 1203 409.91256 Training, Education, and Clinicals in Health 1204 (TEACH) Funding Program.— 1205 (1) PURPOSE AND INTENT.—The Training, Education, and 1206 Clinicals in Health (TEACH) Funding Program is created to 1207 provide a high-quality educational experience while supporting 1208 participating federally qualified health centers, community 1209 mental health centers, rural health clinics, and certified 1210 community behavioral health clinics, and publicly funded 1211 nonprofit organizations serving Medicaid recipients or other 1212 low-income patients in areas designated as health professional 1213 shortage areas and approved by the agency by offsetting 1214 administrative costs and loss of revenue associated with 1215 training residents and students to become licensed health care 1216 practitioners. Further, it is the intent of the Legislature to 1217 use the program to support the state Medicaid program and 1218 underserved populations by expanding the available health care 1219 workforce. 1220 (2) DEFINITIONS.—As used in this section, the term: 1221 (d) “Qualified facility” means a federally qualified health 1222 center, a community mental health center, a rural health clinic, 1223 or a certified community behavioral health clinic, or a publicly 1224 funded nonprofit organization serving Medicaid recipients or 1225 other low-income patients in an area designated as a health 1226 professional shortage area and approved by the agency. 1227 (5) REIMBURSEMENT.—Qualified facilities may be reimbursed 1228 under this section only to offset the administrative costs or 1229 lost revenue associated with training students, allopathic 1230 residents, osteopathic residents, or dental residents who are 1231 enrolled in an accredited educational or residency program based 1232 in this state. 1233 (a) Subject to an appropriation, the agency may reimburse a 1234 qualified facility based on the number of clinical training 1235 hours reported under subparagraph (3)(e)1. The allowed 1236 reimbursement per student is as follows: 1237 1. A medical or dental resident at a rate of $50 per hour. 1238 2. A first-year medical student at a rate of $27 per hour. 1239 3. A second-year medical student at a rate of $27 per hour. 1240 4. A third-year medical student at a rate of $29 per hour. 1241 5. A fourth-year medical student at a rate of $29 per hour. 1242 6. A dental student at a rate of $22 per hour. 1243 7. An advanced practice registered nursing student at a 1244 rate of $22 per hour. 1245 8. A physician assistant student at a rate of $22 per hour. 1246 9. A nursing student at a rate of $22 per hour. 1247 10. A behavioral health student at a rate of $15 per hour. 1248 11.10. A dental hygiene student at a rate of $15 per hour. 1249 Section 16. Paragraph (e) of subsection (3) of section 1250 409.967, Florida Statutes, is amended to read: 1251 409.967 Managed care plan accountability.— 1252 (3) ACHIEVED SAVINGS REBATE.— 1253 (e) Once the certified public accountant completes the 1254 audit, the certified public accountant shall submit an audit 1255 report to the agency attesting to the achieved savings of the 1256 plan. The agency shall review the report to determine compliance 1257 with the requirements of this subsection. The agency shall 1258 notify the certified public accountant of any deficiencies in 1259 the audit report. The certified public accountant must correct 1260 such deficiencies in the audit report and resubmit the revised 1261 audit report to the agency before the report is considered 1262 final. Once finalized, the results of the audit report are 1263 dispositive. 1264 Section 17. Section 409.9745, Florida Statutes, is amended 1265 to read: 1266 409.9745 Managed care plan biomarker testing.— 1267 (1) A managed care plan must provide coverage for biomarker 1268 testing for recipients, as authorized under s. 409.906, at the 1269 same scope, duration, and frequency as the Medicaid program 1270 provides for other medically necessary treatments. 1271 (a)(2) A recipient and health care provider shall have 1272 access to a clear and convenient process to request 1273 authorization for biomarker testing as provided under this 1274 section. Such process shall be made readily accessible on the 1275 website of the managed care plan. 1276 (b)(3) This section does not require coverage of biomarker 1277 testing for screening purposes. 1278 (c)(4) The agency shall include the rate impact of this 1279 section in the applicable Medicaid managed medical assistance 1280 program and long-term care managed care program rates. 1281 (2) A managed care plan must provide coverage for blood 1282 based biomarker tests for colorectal cancer screening covered 1283 under a National Coverage Determination from the Centers for 1284 Medicare and Medicaid Services at the same scope and frequency 1285 as described in the National Coverage Determination. 1286 Section 18. Subsection (4) of section 409.977, Florida 1287 Statutes, is amended to read: 1288 409.977 Enrollment.— 1289 (4) The agency shall develop a process to enable a 1290 recipient with access to employer-sponsored health care coverage 1291 to opt out of all managed care plans and to use Medicaid 1292 financial assistance to pay for the recipient’s share of the 1293 cost in such employer-sponsored coverage. The agency shall also 1294 enable recipients with access to other insurance or related 1295 products providing access to health care services created 1296 pursuant to state law, including any product available under the 1297 Florida Health Choices Program, or any health exchange, to opt 1298 out. The amount of financial assistance provided for each 1299 recipient may not exceed the amount of the Medicaid premium that 1300 would have been paid to a managed care plan for that recipient. 1301 The agency shall require Medicaid recipients with access to 1302 employer-sponsored health care coverage to enroll in that 1303 coverage and use Medicaid financial assistance to pay for the 1304 recipient’s share of the cost for such coverage. The amount of 1305 financial assistance provided for each recipient may not exceed 1306 the amount of the Medicaid premium that would have been paid to 1307 a managed care plan for that recipient. The agency may exceed 1308 this amount for a high-cost patient if it determines it would be 1309 cost effective to do so. The agency shall annually, beginning 1310 June 30, 2026, submit an annual report on the program to the 1311 Legislature including, but not limited to, the level of 1312 participation; participant demographics, income levels, type of 1313 employer-based coverage, and amount of health care utilization; 1314 and a cost-effectiveness analysis both in the aggregate and on 1315 an individual patient basis. 1316 Section 19. Paragraph (b) of subsection (3) of section 1317 430.84, Florida Statutes, is amended to read: 1318 430.84 Program of All-Inclusive Care for the Elderly.— 1319 (3) PACE ORGANIZATION SELECTION.—The agency, in 1320 consultation with the department, shall, on a continuous basis, 1321 review and consider applications required by the CMS for PACE 1322 that have been submitted to the agency by entities seeking 1323 initial state approval to become PACE organizations. Notice of 1324 such applications shall be published in the Florida 1325 Administrative Register. 1326 (b) Each applicant must propose to serve a unique and 1327 defined geographic service area. In designating a service area 1328 under a contract with a PACE organization, the state 1329 administering agency may exclude from designation an area that 1330 is already covered under another PACE organization contract in 1331 order to avoid unnecessary duplication of services and avoid 1332 impairing the financial service viability of an existing PACE 1333 organization. However, if a new applicant submits a letter of 1334 intent to provide PACE services in an area where an existing 1335 PACE organization is under contract and has been operating for 1336 at least 10 years, the state shall determine whether there is an 1337 unmet need that could be provided by the new PACE organization 1338 and the applicant must satisfactorily demonstrate to the state 1339 administering agency that there is justification for the 1340 proposed PACE organization in such service area. All applicants 1341 must demonstrate in the application that the PACE services 1342 provided by the proposed PACE organization will be comprehensive 1343 and organized to meet all state and CMS requirements without 1344 duplication of services or target populations. No more than one 1345 PACE organization may be authorized to provide services within 1346 any unique and defined geographic service area. 1347 Section 20. (1) To support and enhance quality outcomes in 1348 Florida’s nursing homes, the Agency for Health Care 1349 Administration shall contract with a third-party vendor to 1350 conduct a comprehensive study of nursing home quality incentive 1351 programs in other states. 1352 (a) At a minimum, the study must include a detailed 1353 analysis of quality incentive programs implemented in each of 1354 the states examined, identify components of such programs which 1355 have demonstrably improved nursing home quality outcomes, and 1356 provide recommendations to modify or enhance this state’s 1357 existing Medicaid Quality Incentive Program based on its 1358 historical performance and trends since it was first 1359 implemented. 1360 (b) The study must also include: 1361 1. An in-depth review of emerging and existing technologies 1362 applicable to nursing home care and an analysis of how their 1363 adoption in this state could improve quality of care, 1364 operational efficiency, and quality of life outcomes for nursing 1365 home residents; and 1366 2. An examination of other states’ Medicaid add-on payment 1367 structures related to the provision of ventilator care, 1368 bariatric services, and behavioral health services. 1369 (2) The agency shall submit a final report on the study, 1370 including findings and actionable recommendations, to the 1371 Governor, the President of the Senate, and the Speaker of the 1372 House of Representatives by January 5, 2026. 1373 Section 21. This act shall take effect July 1, 2025.

Official text from the Florida Legislature. Formatting has been adapted for reading on Ratifi.